Inventor
RAPKIN MYRON
US50 patents
⚠️ This page may combine multiple inventors who share the name “RAPKIN MYRON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
POP TEST ONCOLOGY LLC
16 patentsUS10537586B2Jan 21, 2020
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC12 citations94
US10238666B2Mar 26, 2019
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LLC11 citations92
US9855284B2Jan 2, 2018
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LLC11 citations92
US11224599B2Jan 18, 2022
Therapeutic agents and methods
POP TEST ONCOLOGY LLC9 citations85
US11040037B2Jun 22, 2021
Therapeutic agents and methods
POP TEST ONCOLOGY LLC10 citations85
US11576921B2Feb 14, 2023
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LLC5 citations84
US11364252B2Jun 21, 2022
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC5 citations84
US11116775B2Sep 14, 2021
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC5 citations84
US10231982B2Mar 19, 2019
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC5 citations84
US10076528B2Sep 18, 2018
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC6 citations84
US10058563B2Aug 28, 2018
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC5 citations84
US9861643B2Jan 9, 2018
System and method for diagnosis and treatment
POP TEST ONCOLOGY LLC5 citations84
US10517881B2Dec 31, 2019
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LLC9 citations82
US11702443B2Jul 18, 2023
Therapeutic agents and methods
POP TEST ONCOLOGY LLC2 citations72
US12263178B2Apr 1, 2025
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LLC0 citations55
US12227727B2Feb 18, 2025
Medical devices and uses thereof
POP TEST ONCOLOGY LLC0 citations52
POP TEST ABUSE DETERRENT TECH LLC
9 patentsUS9878138B2Jan 30, 2018
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC26 citations97
US10010703B2Jul 3, 2018
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC9 citations92
US9878139B2Jan 30, 2018
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC13 citations92
US10245323B2Apr 2, 2019
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC3 citations84
US10137288B2Nov 27, 2018
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC3 citations84
US11527315B2Dec 13, 2022
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC2 citations73
US10625063B2Apr 21, 2020
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC2 citations73
US12205696B2Jan 21, 2025
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC0 citations62
US10441762B2Oct 15, 2019
Drug device configured for wireless communication
POP TEST ABUSE DETERRENT TECH LLC0 citations52
Pop Test LLC
9 patentsUS9005914B2Apr 14, 2015
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC9 citations84
US9662392B2May 30, 2017
Drug device configured for wireless communication
Pop Test LLC7 citations83
US10160994B2Dec 25, 2018
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC2 citations68
US9957547B2May 1, 2018
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC0 citations52
US9651545B1May 16, 2017
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC0 citations52
US9562256B2Feb 7, 2017
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC0 citations52
US9366674B2Jun 14, 2016
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
Pop Test LLC1 citations52
US10653447B2May 19, 2020
Method of using an intradermal applicator for delivering a sensor within the skin
Pop Test LLC0 citations51
US10441316B2Oct 15, 2019
Intradermal applicator/analyte sensor placement using fluorescence
Pop Test LLC0 citations51
POP TEST ONCOLOGY LTD LIABILITY COMPANY
6 patentsUS9314473B2Apr 19, 2016
System and method for diagnosis and treatment
POP TEST ONCOLOGY LTD LIABILITY COMPANY45 citations97
US9320747B1Apr 26, 2016
System and method for diagnosis and treatment
POP TEST ONCOLOGY LTD LIABILITY COMPANY33 citations94
US9598459B2Mar 21, 2017
Pharmaceutical compositions and methods
POP TEST ONCOLOGY LTD LIABILITY COMPANY11 citations92
US9642866B2May 9, 2017
System and method for diagnosis and treatment
POP TEST ONCOLOGY LTD LIABILITY COMPANY5 citations84
US9636351B2May 2, 2017
System and method for diagnosis and treatment
POP TEST ONCOLOGY LTD LIABILITY COMPANY7 citations84
US9295680B2Mar 29, 2016
System and method for diagnosis and treatment
POP TEST ONCOLOGY LTD LIABILITY COMPANY6 citations84
ALTSCHUL RANDICE LISA
5 patentsUS8658128B2Feb 25, 2014
System and method for diagnosis and treatment
ALTSCHUL RANDICE LISA68 citations98
US8889427B2Nov 18, 2014
Diagnostic device
ALTSCHUL RANDICE LISA4 citations73
US8865693B2Oct 21, 2014
Prevention of infection
ALTSCHUL RANDICE LISA2 citations63
US8431386B2Apr 30, 2013
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
ALTSCHUL RANDICE LISA0 citations52
US8263328B2Sep 11, 2012
Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
ALTSCHUL RANDICE LISA0 citations52